Opportunity ID: 47329

General Information

Document Type: Grants Notice
Funding Opportunity Number: DTNH22-09-R-00249
Funding Opportunity Title: Promote Pharmacist Education on Potentially Driver Impairing Drugs
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 20.614 — National Highway Transportation Safety Administration (NHTSA) Discretionary Safety Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 12, 2009
Last Updated Date: May 13, 2009
Original Closing Date for Applications: Jun 12, 2009
Current Closing Date for Applications: Jun 12, 2009
Archive Date: Jul 12, 2009
Estimated Total Program Funding:
Award Ceiling: $250,000
Award Floor: $250,000

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: National Highway Traffic Safety Administration
Description: UNITED STATES DEPARTMENT OF TRANSPORTATION (U.S. DOT)
National Highway Traffic Safety Administration (NHTSA)

Cooperative Agreement for: Pharmacist Education on Potentially Driver Impairing Drugs

AGENCY: National Highway Traffic Safety Administration (NHTSA), U.S. Department of Transportation (DOT)

ACTION: Announcement of a Request for Applications to promote Pharmacist Education on Potentially Driver-Impairing Drugs. Competition under this RFA is restricted to competition among state governments, academic institutions, non-profit organizations and for profit organizations. It is anticipated that one (1) award will be made for this project (not to exceed $250,000) total.

SUMMARY: The objective of this cooperative agreement is to ensure the longevity of the online training course on potentially-driver-impairing drugs and to see that is remains relevant beyond its current CE certification. NHTSA wishes to partner with an organization that can promote the course to pharmacists and pharmacy technicians, and enable the recertification of the course at the end of its current certification.
.

DATES: Application(s) must be submitted to the National Highway Traffic Safety Administration, Office of Acquisition Management (NPO-320); Attention: Sherese A. Gray, 1200 New Jersey Avenue, S.E., W51-121, Washington, D.C. 20590. All application(s) submitted must include a reference to NHTSA Cooperative Agreement Number DTNH22-09-R-00249. Only complete packages received on or before 3:00 P.M. Eastern Standard Time on Friday, June 12, 2009 will be considered.

Applicant(s) shall provide a complete mailing address where Federal Express mail can be delivered.

FOR FURTHER INFORMATION CONTACT: General administrative and programmatic questions may be directed to Sherese A. Gray, Contract Specialist, Office of Acquisition Management, by email at sherese.gray@dot.gov. To allow for sufficient time to address questions appropriately, all questions must be received no later than 3:00 P.M. Eastern Daylight Time, Tuesday, May 19, 2009 via e-mail.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Sherese Gray

Contract Specialist

Email:sherese.gray@dot.gov

Version History

Version Modification Description Updated Date
There was a typo in the title of this opportunity:

It should read "Pharmacist"

May 13, 2009
May 13, 2009

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: DTNH22-09-R-00249
Funding Opportunity Title: Promote Pharmacist Education on Potentially Driver Impairing Drugs
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 20.614 — National Highway Transportation Safety Administration (NHTSA) Discretionary Safety Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 12, 2009
Last Updated Date: May 13, 2009
Original Closing Date for Applications: Jun 12, 2009
Current Closing Date for Applications: Jun 12, 2009
Archive Date: Jul 12, 2009
Estimated Total Program Funding:
Award Ceiling: $250,000
Award Floor: $250,000

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: National Highway Traffic Safety Administration
Description: UNITED STATES DEPARTMENT OF TRANSPORTATION (U.S. DOT)
National Highway Traffic Safety Administration (NHTSA)

Cooperative Agreement for: Pharmacist Education on Potentially Driver Impairing Drugs

AGENCY: National Highway Traffic Safety Administration (NHTSA), U.S. Department of Transportation (DOT)

ACTION: Announcement of a Request for Applications to promote Pharmacist Education on Potentially Driver-Impairing Drugs. Competition under this RFA is restricted to competition among state governments, academic institutions, non-profit organizations and for profit organizations. It is anticipated that one (1) award will be made for this project (not to exceed $250,000) total.

SUMMARY: The objective of this cooperative agreement is to ensure the longevity of the online training course on potentially-driver-impairing drugs and to see that is remains relevant beyond its current CE certification. NHTSA wishes to partner with an organization that can promote the course to pharmacists and pharmacy technicians, and enable the recertification of the course at the end of its current certification.
.

DATES: Application(s) must be submitted to the National Highway Traffic Safety Administration, Office of Acquisition Management (NPO-320); Attention: Sherese A. Gray, 1200 New Jersey Avenue, S.E., W51-121, Washington, D.C. 20590. All application(s) submitted must include a reference to NHTSA Cooperative Agreement Number DTNH22-09-R-00249. Only complete packages received on or before 3:00 P.M. Eastern Standard Time on Friday, June 12, 2009 will be considered.

Applicant(s) shall provide a complete mailing address where Federal Express mail can be delivered.

FOR FURTHER INFORMATION CONTACT: General administrative and programmatic questions may be directed to Sherese A. Gray, Contract Specialist, Office of Acquisition Management, by email at sherese.gray@dot.gov. To allow for sufficient time to address questions appropriately, all questions must be received no later than 3:00 P.M. Eastern Daylight Time, Tuesday, May 19, 2009 via e-mail.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Sherese Gray

Contract Specialist

Email:sherese.gray@dot.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: DTNH22-09-R-00249
Funding Opportunity Title: Promote Pharmist Education on Potentially Driver Impairing Drugs
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Assistance Listings: 20.614 — National Highway Transportation Safety Administration (NHTSA) Discretionary Safety Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 13, 2009
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 12, 2009
Archive Date: Jul 12, 2009
Estimated Total Program Funding:
Award Ceiling: $250,000
Award Floor: $250,000

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: National Highway Traffic Safety Administration
Description: UNITED STATES DEPARTMENT OF TRANSPORTATION (U.S. DOT)
National Highway Traffic Safety Administration (NHTSA)

Cooperative Agreement for: Pharmacist Education on Potentially Driver Impairing Drugs

AGENCY: National Highway Traffic Safety Administration (NHTSA), U.S. Department of Transportation (DOT)

ACTION: Announcement of a Request for Applications to promote Pharmacist Education on Potentially Driver-Impairing Drugs. Competition under this RFA is restricted to competition among state governments, academic institutions, non-profit organizations and for profit organizations. It is anticipated that one (1) award will be made for this project (not to exceed $250,000) total.

SUMMARY: The objective of this cooperative agreement is to ensure the longevity of the online training course on potentially-driver-impairing drugs and to see that is remains relevant beyond its current CE certification. NHTSA wishes to partner with an organization that can promote the course to pharmacists and pharmacy technicians, and enable the recertification of the course at the end of its current certification.
.

DATES: Application(s) must be submitted to the National Highway Traffic Safety Administration, Office of Acquisition Management (NPO-320); Attention: Sherese A. Gray, 1200 New Jersey Avenue, S.E., W51-121, Washington, D.C. 20590. All application(s) submitted must include a reference to NHTSA Cooperative Agreement Number DTNH22-09-R-00249. Only complete packages received on or before 3:00 P.M. Eastern Standard Time on Friday, June 12, 2009 will be considered.

Applicant(s) shall provide a complete mailing address where Federal Express mail can be delivered.

FOR FURTHER INFORMATION CONTACT: General administrative and programmatic questions may be directed to Sherese A. Gray, Contract Specialist, Office of Acquisition Management, by email at sherese.gray@dot.gov. To allow for sufficient time to address questions appropriately, all questions must be received no later than 3:00 P.M. Eastern Daylight Time, Tuesday, May 19, 2009 via e-mail.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Sherese Gray

Contract Specialist

Email:sherese.gray@dot.gov

Folder 47329 Full Announcement-1 -> dtnh22-09-r-00249 (pharmacist ed) (2).pdf

Packages

Agency Contact Information: Sherese Gray
Contract Specialist

Email: sherese.gray@dot.gov

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
20.614 PKG00012100 May 12, 2009 Jun 12, 2009 View

Package 1

Mandatory forms

47329 SF424_Mandatory-1.1.pdf

47329 SF424A-1.0.pdf

47329 Mandatory_SF424B-1.1.pdf

2025-07-10T08:34:07-05:00

Share This Post, Choose Your Platform!

About the Author: